Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

FDA logo

Heartbreak for Novartis as FDA rejects drug

May 18, 2014
Research and Development, Sales and Marketing GSK, Novartis, heart drug

Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …

News
Avastin image

EU looks at eye drug allegations

May 8, 2014
Sales and Marketing EU, Lucentis, Novartis, Roche, avastin, offlabel

European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …

News
Bayer image

Bayer to make $14 bn move for Merck unit

May 2, 2014
Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Merck, Novartis, Reckitt Benckiser, claritin, reuters

Bayer is in talks with Merck & Co to buy its consumer business and is willing to pay $14 billion …

News
GSK image

GSK sees profit fall

May 1, 2014
Sales and Marketing Advair, China, GSK, Novartis, Q1, Seretide, Witty

GlaxoSmithKline has seen revenue and profit plummet in the first quarter of 2014. The UK-based company saw turnover fall 13% …

News
Novartis image

FDA approves Zykadia for late-stage lung cancer

April 30, 2014
Research and Development, Sales and Marketing Cancer, FDA, Novartis, lung, zykadia

Novartis’ ‘breakthrough’ drug Zykadia has been approved by the FDA to treat lung cancer patients with a particular genetic mutation. …

News

Novartis reports healthy profit

April 25, 2014
Sales and Marketing Afinitor, Gleevec, Glivec, Novartis, Q1, lilly

Multiple sclerosis drug Gilenya and cancer treatment Afinitor were among the biggest sellers for Novartis, as the Swiss company’s net …

News
Allergan image

Valeant makes $45.7 billion Allergan offer

April 23, 2014
Sales and Marketing Allergan, Botox, GSK, Novartis, Pfizer, Valeant, merger, pershing

In the latest proposal in a flurry of merger and acquisition activity in the pharma sector, Valeant Pharmaceuticals International wants …

News

GSK and Novartis sign multi-billion dollar deal

April 23, 2014
Research and Development, Sales and Marketing GSK, Novartis, Tafinlar, lilly, merger, tykerb, vaccines

GlaxoSmithKline and Novartis are radically shaking up their businesses, starting up a joint venture while selling off major parts of …

News
Horsham image

Novartis ponders Horsham site future

April 14, 2014
Research and Development, Sales and Marketing Horsham, Novartis, Osborne, PharmaVentures, medcity, research, site

Novartis has hired specialist consultancy firm PharmaVentures to help it decide how to re-use it former Horsham site. This comes …

News
roche_logo_shadow

Roche/Novartis offices raided over anti-competitive activities

April 11, 2014
Sales and Marketing Lucentis, Novartis, Roche, SHIP Cluster, avastin, wet AMD

French competition authorities are investigating Roche and Novartis in connection with their marketing of Lucentis for wet age-related macular degeneration …

News
jeff_george_sandoz

Novartis appoints new heads at Alcon, Sandoz

April 9, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alcon, Novartis, Sandoz

Appointment
patientslikeme

Roche joins forces with PatientsLikeMe

April 8, 2014
Medical Communications, Research and Development, Sales and Marketing Novartis, PatientsLikeMe, Roche, UCB, real-word data

PatientsLikeMe has set up a five-year agreement with Genentech, Roche’s biologics arm, to allow the firm access to patients’ real-world …

News
Biocon image

Novartis sues Biocon

April 4, 2014
Sales and Marketing Biocon, Galvus, Gilead, Herceptin, Novartis, sofosbuvir

India’s status as a battleground for patent issues has been reinforced with the news that Novartis is suing Biocon over …

News
Novartis image

FDA unconvinced on Novartis heart drug

March 26, 2014
Research and Development, Sales and Marketing FDA, Novartis, ahf, heart, serelaxin

The prospects of Novartis’ latest heart drug being approved in the US anytime soon appear to have been scuppered by …

News

Xolair gets FDA approval for skin condition

March 24, 2014
Research and Development, Sales and Marketing FDA, Novartis, Roche, Sanofi, Xolair, chronic hives, csu

 An asthma drug developed by Roche subsidiary Genentech and Novartis has been granted an additional indication to treat chronic hives …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025